Skip to content 
Cabenuva is a 2-drug co-packaged product of cabotegravir and rilpivirine. It is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35kg to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) with no history of treatment failure.
It is an IV infusion once weekly for 4 weeks. It is given over 1 hour with a 1 hour observation period after the infusion.
The most common adverse reactions (≥ 10%) in patients treated with gMG are: respiratory tract infections, headache, and urinary tract infection.
In clinical trials, participants achieved significant improvements with daily activities (68% of patients) and a reduction in muscle weakness (63% of patients) when Vyvgart was added to current gMG treatment.
Cabenuva is an injection that can be given monthly or every 2 months depending on your medical providers’ recommendation.
The most common side effects of CABENUVA include:
● pain, tenderness, lump, swelling, redness, itching, bruising, and warmth at the injection site
● Fever, tiredness, headache, muscle or bone pain, nausea, sleep problems, dizziness, rash
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.
